What is Bayer Cropscience Ltd. Quarterly Revenue?

Bayer Cropscience Ltd. Quarterly Revenue Bayer Cropscience Jun-2026 Quarterly Revenue is Rs 1,924 Cr which is growth of -0.5% YoY.

What is Bayer Cropscience Ltd. Quarterly Net Profit?

Bayer Cropscience Ltd. Quarterly Net Profit Bayer Cropscience Jun-2026 Quarterly Net Profit is Rs 322 Cr which is growth of 15.4% YoY.

What is Bayer Cropscience Ltd. Annual Revenue?

Bayer Cropscience Ltd. Annual Revenue Bayer Cropscience Mar-2026 Annual Revenue is Rs 5,770 Cr which is growth of 3.2% YoY.

What is Bayer Cropscience Ltd. Annual Net Profit?

Bayer Cropscience Ltd. Annual Net Profit Bayer Cropscience Mar-2026 Annual Net Profit is Rs 689 Cr which is growth of 21.3% YoY.

What is Bayer Cropscience Ltd. Total Shareholders Fund?

Bayer Cropscience Ltd. Total Shareholders Fund Bayer Cropscience Mar-2026 Total Shareholders Fund is Rs 2,966 Cr which is growth of 4.0% YoY.

What is Bayer Cropscience Ltd. Total Assets?

Bayer Cropscience Ltd. Total Assets Bayer Cropscience Mar-2026 Total Assets is Rs 5,699 Cr which is growth of 8.6% YoY.

What is Bayer Cropscience Ltd. Book Value Per Share?

Bayer Cropscience Ltd. Book Value Per Share Bayer Cropscience Mar-2026 Book Value Per Share is 661 Rs which is growth of 4.0% YoY.

What is Bayer Cropscience Ltd. ROE?

Bayer Cropscience Ltd. ROE Bayer Cropscience Mar-2026 ROE is 23% which is growth of 3.3% YoY.

What is Bayer Cropscience Ltd. Cash From Operating Activity?

Bayer Cropscience Ltd. Cash From Operating Activity Bayer Cropscience Mar-2026 Cash From Operating Activity is Rs 1,078 Cr which is growth of 311.6% YoY.

What is Bayer Cropscience Ltd. Net Cash Flow?

Bayer Cropscience Ltd. Net Cash Flow Bayer Cropscience Mar-2026 Net Cash Flow is Rs 527 Cr which is growth of 294.0% YoY.

Bayer Cropscience Ltd.

NSE: BAYERCROP | BSE: 506285

Falling Comet

Download real time

-4.40(-0.12%)

New 52W Low today

67,497

NSE+BSE Volume

High volume today

NSE 21 Sep, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Bayer Cropscience quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Bayer Cropscience share price target, revenues, EPS, net income and more

Bayer Cropscience quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

NEGATIVE
Quarterly Revenue Bayer Cropscience Jun-2026 Quarterly Revenue is Rs 1,924 Cr which is growth of -0.5% YoY.
POSITIVE
Quarterly Net Profit Bayer Cropscience Jun-2026 Quarterly Net Profit is Rs 322 Cr which is growth of 15.4% YoY.

Bayer Cropscience Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	1,923.9	1,147.4	1,122.1	1,567.2	1,933.3	1,083.5	1,089.6	1,761.3	1,658.7	821.1	969.5	1,633.3	1,760.3
SR_Q Operating Rev.	1,835	1,100.8	1,106.2	1,553.4	1,914.6	1,046.4	1,056.9	1,737.6	1,631.2	791.5	954.9	1,617.2	1,739.6
OI_Q Other Income	88.9	46.6	15.9	13.8	18.7	37.1	32.7	23.7	27.5	29.6	14.6	16.1	20.7
OEXPNS_Q Operating Exp.	1,467.4	897.9	989.1	1,348.1	1,566.2	875.6	1,037.2	1,553.8	1,317.2	694.9	827	1,312.3	1,315
OEXPNS_Q Operating Exp.	1,467.4	897.9	989.1	1,348.1	1,566.2	875.6	1,037.2	1,553.8	1,317.2	694.9	827	1,312.3	1,315
OP_Q Operating Profit	367.6	202.9	117.1	205.3	348.4	170.8	19.7	183.8	314	96.6	127.9	304.9	424.6
OPMPCT_Q Operating Profit Margin %	20.03%	18.43%	10.59%	13.22%	18.20%	16.32%	1.86%	10.58%	19.25%	12.20%	13.39%	18.85%	24.41%
DEP_Q Depr.	50.1	37.6	14.8	14.4	27.2	34.3	15.1	14	21.5	15.9	15.2	11.6	31.3
INT_Q Interest	4.3	5.5	5.2	4.4	4.7	5.7	3.7	3.4	4.2	4.9	3.1	3.7	7.9
PBT_Q Profit Before Tax	402.1	206.4	113	200.3	335.2	167.9	33.6	190.1	315.8	105.4	124.2	305.7	406.1
TAX_Q Tax	80.5	44.3	17.3	47.6	56.5	24.6	-0.6	53.8	61.6	9.4	31.1	82.8	77.6
NP_Q Net Profit	321.6	162.1	95.7	152.7	278.7	143.3	34.2	136.3	254.2	96	93.1	222.9	328.5
EPS_adj_Q EPS Adj. latest	71.6	36.1	21.3	34	62	31.9	7.6	30.3	56.6	21.4	20.7	49.6	73.1
NP_TTM Net profit TTM	732.1	689.2	670.4	608.9	592.5	568	520.7	579.6	666.2	740.5	803	844.4	784.1
EPS_TTM Basic EPS TTM	163.1	153.5	149.3	135.6	132	126.5	116	129.1	148.4	164.9	178.8	188.1	174.6
earnings_transcripts Earnings Transcripts
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Bayer Cropscience competitor comparison and performance snapshot within industry

Bayer Cropscience annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Bayer Cropscience Mar-2026 Annual Revenue is Rs 5,770 Cr which is growth of 3.2% YoY.
POSITIVE
Annual Net Profit Bayer Cropscience Mar-2026 Annual Net Profit is Rs 689 Cr which is growth of 21.3% YoY.

Bayer Cropscience Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	3.5%	5.9%	5,760.6	5,770	5,593.1	5,184.2	5,203.6	4,789	4,325.1	3,675.4	3,220.4	2,748.7	2,872.9	3,818.6
TotalOperatingRevenues_A Operating Rev. Ann.	3.4%	5.9%	5,595.4	5,675	5,473.4	5,103.2	5,139.7	4,734.4	4,261.3	3,609.4	3,167.3	2,709.9	2,802.8	3,742.9
OI_A Other Income Ann.	14.1%	8.3%	165.2	95	119.7	81	63.9	54.6	63.8	66	53.1	38.8	70.1	75.7
OEXPNS_A Operating Exp. Ann.	4.4%	6.8%	4,702.5	4,801.3	4,783.8	4,149.2	4,215.5	3,923.3	3,449.6	2,883	2,686.2	2,300.5	2,389.2	3,323.7
OEXPNS_A Operating Exp. Ann.	4.4%	6.8%	4,702.5	4,801.3	4,783.8	4,149.2	4,215.5	3,923.3	3,449.6	2,883	2,686.2	2,300.5	2,389.2	3,323.7
OP_A Operating Profit Ann.	-1.9%	1.5%	892.9	873.7	689.6	954	924.2	811.1	811.7	726.4	481.1	409.4	413.6	419.2
OPMPCT_A OPM Ann. %	-5.2%	-4.2%		15.14%	12.33%	18.40%	17.76%	16.94%	18.77%	19.76%	14.94%	14.89%	14.40%	10.98%
TotalExpenses_A Total Exp. Ann. ⌄	4.4%	6.8%		4,915.1	4,885.7	4,242.8	4,317.3	4,000.7	3,535.7	2,962.1	2,740.4	2,344.9	2,425	3,355.7
OtherExpenses_A Other Exp. Ann.	4.4%	9%	1,012.2	985.7	935.2	786.7	865.2	796	641.5	611.6	660.6	436	497.2	610.2
EmployeeBenefitExpenses_A Employee Exp. Ann.	-6.4%	3.9%	446.6	438.1	449.8	435.4	534.3	463.1	362.2	361.6	364.2	263.9	245.9	225.3
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	-0.7%	2%		968.7	809.3	1,035	988.1	865.7	875.5	792.4	534.2	448.2	483.7	494.9
EBIDTPCT_A EBITDA Ann. margin %	-4%	-3.7%		16.79%	14.47%	19.96%	18.99%	18.08%	20.24%	21.56%	16.59%	16.31%	16.84%	12.96%
INT_A Interest Ann.	-3.9%	9.5%	19.4	19.8	17	19.6	22.3	12.9	12.6	13.8	10.4	11.3	6.9	7.3
DEP_A Depr.	5.7%	5%	116.9	94	84.9	74	79.5	64.5	73.5	65.3	43.8	33.1	28.9	24.7
PBT_A PBT Ann.	-4.8%	1.5%	921.8	854.9	707.4	941.4	990.1	846.8	794.5	583.1	480	403.8	447.9	462.9
TAX_A Tax Ann.	-10.6%	-11.3%	189.7	165.7	139.4	200.9	231.9	201.5	301.4	108.6	142.9	103.7	156.9	162
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	-3.1%	6.9%		689.2	568	740.5	758.2	645.3	493.1	474.5	337.1	300.1	291	300.9
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	-3.1%	6.9%	732.1	689.2	568	740.5	758.2	645.3	493.1	474.5	337.1	300.1	291	300.9
NETPCT_A NPM Ann. %	-6.3%	1%		12.14%	10.37%	14.51%	14.75%	13.63%	11.57%	13.14%	10.64%	11.07%	10.38%	8.03%
EPS_adj_A EPS Adj. latest Ann.	-3.1%	6.9%		153.4	126.4	164.8	168.7	143.6	109.7	105.6	75	66.8	64.8	67
result_notes Result Notes				Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

3.2%

2Y CAGR

5.5%

3Y CAGR

3.5%

5Y CAGR

5.9%

7Y CAGR

8.7%

10Y CAGR

4.2%

Total Revenue Annual growth is lower than historical averages.

Net Profit Ann.

1Y CHG

21.3%

2Y CAGR

-3.5%

3Y CAGR

-3.1%

5Y CAGR

6.9%

7Y CAGR

10.8%

10Y CAGR

8.6%

Net Profit Annual growth is higher than historical averages.

Operating Exp. Ann.

1Y CHG

0.4%

2Y CAGR

7.6%

3Y CAGR

4.4%

5Y CAGR

6.8%

7Y CAGR

8.7%

10Y CAGR

3.7%

Operating Expenses Annual Cr growth is lower than historical averages.

Bayer Cropscience balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Bayer Cropscience Mar-2026 Total Shareholders Fund is Rs 2,966 Cr which is growth of 4.0% YoY.
POSITIVE
Total Assets Bayer Cropscience Mar-2026 Total Assets is Rs 5,699 Cr which is growth of 8.6% YoY.

Bayer Cropscience Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	3%	3.1%	2,965.7	2,850.4	2,849.4	2,712.1	2,524.3	2,550.3	2,572.5	2,228.8	1,778.3	2,056.7	1,755.9
EQCAP_A Equity Share Capital Ann.	0%	0%	44.9	44.9	44.9	44.9	44.9	44.9	44.9	34.3	34.3	35.4	35.4
TotalShareCapital_A Total Share Capital Ann.	0%	0%	44.9	44.9	44.9	44.9	44.9	44.9	44.9	34.3	34.3	35.4	35.4
ReservesAndSurplus_A Reserves Plus Surplus Ann.	3.1%	3.1%	2,920.8	2,805.5	2,804.5	2,667.2	2,479.4	2,505.4	2,527.6	2,194.5	1,744	2,021.3	1,720.5
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	3.1%	3.1%	2,920.8	2,805.5	2,804.5	2,667.2	2,479.4	2,505.4	2,527.6	2,194.5	1,744	2,021.3	1,720.5
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	-4.2%	7%	166.2	171.8	150.3	189	169.3	118.4	123.8	121.9	94.6	85.6	65.7
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-			4	0.3					10.4	2
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	2.2%	22.4%	38.8	61.6	21	36.4	51.8	14.1	13.8	0.1			9.4
CL_A Total Current Liabilities Ann. ⌄	13%	10.3%	2,567.5	2,223.7	1,597.4	1,777.5	1,659.3	1,570.6	1,139.4	1,187.9	661.9	683.1	616.7
TradePayables_A Trade Payables Ann.	12.3%	8.3%	1,237.9	1,098.4	605.1	873.2	819.8	830.3	474.9	644.2	283.8	287.4	245.3
OtherCurrentLiabilities_A Other Current Liabilities Ann.	15.8%	12.7%	1,227.7	1,038.2	940.5	791.3	729.7	676.6	588.6	475	184.2	183.5	283.2
ShortTermProvisions_A ST Provisions Ann.	-3.4%	9.9%	101.9	87.1	51.8	113	109.8	63.7	74.4	68.7	193.9	212.2	88.2
TL_A Total Capital Plus Liabilities Ann.	6.8%	6.1%	5,699.4	5,245.9	4,597.1	4,678.6	4,352.9	4,239.3	3,835.7	3,549.2	2,534.8	2,825.4	2,438.3
FixedAssets_A Fixed Assets Ann. ⌄	0.8%	3.2%	585.8	588.4	533.1	571.6	565.8	501	524.4	487.4	370.5	366.1	325.1
TangibleAssets_A Tangible Assets Ann.	-2.1%	0.4%	401.5	426.9	376.2	428.4	437.1	393.2	436.3	406.7	300	305.2	315.6
IntangibleAssets_A Intangible Assets Ann.	57.5%	85.3%	32.8	18.2	13.2	8.4	4.3	1.5	1.7	2.6	4.2	6.1	2.5
CapitalWorkInProgress_A Capital Work In Progress Ann.	19.1%	-8.4%	4.9	0.5	6.4	2.9	13.3	7.6	3.6	7.2	1.2	1	6.7
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	0%	2.4%	781.1	774.3	691.6	782.2	777.4	695.4	821.3	769.4	458.7	451.2	407.5
NonCurrentInvestments_A Non Current Investments Ann.	-	-											3.4
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-7.1%	12.4	9.7			7.3	17.9	27	8.9			6.9
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-											72.1
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-4.6%	0.7%	182.9	176.2	158.5	210.6	204.3	176.5	269.9	273.1	88.2	85.1
CA_A Total Current Assets Ann. ⌄	8.1%	6.8%	4,918.3	4,471.6	3,905.5	3,896.4	3,575.5	3,543.9	3,014.4	2,779.8	2,076.1	2,374.2	2,030.8
CurrentInvestments_A Current Investments Ann.	11.8%	1.9%	57.4	35.4	53.9	41.1	38.5	52.2	40.8			49.7	36.4
TradeReceivables_A Trade Receivables Ann.	4.6%	8.1%	1,115.5	952.1	960.1	975.6	1,004.7	754.9	718	698.6	658.8	556.5	496.3
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	17.9%	3.3%	1,421.8	893.7	1,164	868	787.4	1,209.5	1,071	582	417.8	839	763.2
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-											71.4
OtherCurrentAssets_A Other Current Assets Ann.	-2.7%	-1.4%	188.1	228.6	182.3	204.5	232.9	202.2	221.1	342.2	259.6	160.9	5.3
TA_A Total Assets Ann.	6.8%	6.1%	5,699.4	5,245.9	4,597.1	4,678.6	4,352.9	4,239.3	3,835.7	3,549.2	2,534.8	2,825.4	2,438.3
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	28.1%	21.8%	783	695.8	562.9	372.7	366.6	292.3	737.4	683.4	136.8	128.2	227.2
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	0%	11	11	11	11	11	11	11	11	11	11.3	11.3
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-											3.4
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	11.8%	1.9%	57.4	35.4	53.9	41.1	38.5	52.2	40.8				36.4

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

8.6%

2Y CAGR

11.3%

3Y CAGR

6.8%

5Y CAGR

6.1%

7Y CAGR

10Y CAGR

8.9%

Total Assets Annual growth is higher than historical averages.

Total Current Liabilities Ann.

1Y CHG

15.5%

2Y CAGR

26.8%

3Y CAGR

13%

5Y CAGR

10.3%

7Y CAGR

11.6%

10Y CAGR

15.3%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

2Y CAGR

3Y CAGR

5Y CAGR

3.1%

7Y CAGR

4.2%

10Y CAGR

5.4%

Total ShareHolders Funds Annual growth is stable compared to historical averages.

Bayer Cropscience ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Bayer Cropscience Mar-2026 Book Value Per Share is 661 Rs which is growth of 4.0% YoY.
POSITIVE
ROE Bayer Cropscience Mar-2026 ROE is 23% which is growth of 3.3% YoY.

Bayer Cropscience Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	3%	3.1%	660.5	634.8	634.6	604	562.2	568	572.9	649.8	518.5	581	496
ROA_A RoA Ann. %	-9.3%	0.8%	12.09%	10.82%	16.10%	16.20%	14.82%	11.63%	12.37%	9.49%	11.83%	10.29%	12.34%
ROE_A ROE Ann. %	-6%	3.7%	23.23%	19.92%	25.98%	27.95%	25.56%	19.33%	18.44%	15.12%	16.87%	14.14%	17.13%
ROCE_A ROCE Ann. %	-3.7%	-1.5%	27.92%	23.96%	32.03%	31.31%	29.74%	30.05%	26.96%	20.76%	22.16%	21.22%	25.81%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	-3.9%	-3.6%	17.06%	14.78%	20.28%	19.22%	18.28%	20.54%	21.95%	16.86%	16.53%	17.25%	13.22%
PBITMargin_A EBIT Ann. Margin %	-4.5%	-3.9%	15.41%	13.23%	18.83%	17.67%	16.92%	18.82%	20.14%	15.48%	15.31%	16.22%	12.56%
PBTMargin_A PBT Ann. Margin %	-7.9%	-4.2%	15.06%	12.92%	18.44%	19.26%	17.88%	18.64%	16.15%	15.15%	14.90%	15.98%	12.36%
NETPCT_A NPM Ann. %	-6.3%	1%	12.14%	10.37%	14.51%	14.75%	13.63%	11.57%	13.14%	10.64%	11.07%	10.38%	8.03%
ASETTO_A Asset Turnover Ann. %	-3.1%	-1.9%	1	1.1	1.1	1.1	1.1	1.1	1	1	1	1.1	1.4
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-4.8%	-3.7%	1.9	2	2.4	2.2	2.2	2.3	2.7	2.3	3.1	3.5	3.3
QuickRatio_A Quick Ratio Ann.	-2.9%	-4.7%	1.1	1	1.5	1.2	1.2	1.4	1.8	1.4	2	2.4	2.2
DividendPayoutNP_A Dividend Payout to NP Ann.	4.6%	-6.2%	0.8	1	0.8	0.7	1	1.1	0.2	0.3	0.3	0.3	0.3
EarningRetention_A Earning Retention Ann. %	-10.6%	-	18.49%	1.10%	18.07%	25.91%	-4.47%	-4.82%	78.59%	62.18%	79.98%	79.35%	80.03%
CashEarningRetention_A Cash Earning Retention Ann. %	-5%	26.3%	28.27%	13.96%	25.52%	32.94%	5.02%	8.78%	81.18%	66.53%	81.97%	81.22%	81.55%
CashEarningRetention_A Cash Earning Retention Ann. %	-5%	26.3%	28.27%	13.96%	25.52%	32.94%	5.02%	8.78%	81.18%	66.53%	81.97%	81.22%	81.55%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	4%	-3%	19,463.9	21,230.1	22,377.3	17,307.3	21,584	22,612.2	14,460.3	14,456.5	13,998.5	12,591.9	12,578
EVPerNetSales_A EV Per Net Sales Ann.	0%	-8.5%	3.4	3.9	4.4	3.4	4.6	5.3	4	4.6	5.2	4.5	3.4
PBV_A Price To Book Value Adjusted	-2.9%	-2.9%	5.72	5.5	5.94	6.24	6.71	6.64	6.58	5.8	7.27	6.51	7.62
EVPerEBITDA_A EV Per EBITDA Ann.	4.7%	-4.9%	20.1	26.2	21.6	17.5	24.9	25.8	18.3	27.1	31.2	26	25.4
MarketCapPerSales_A Market Cap Per Sales Ann.	1.9%	-8%	3.7	4	4.6	3.5	4.7	5.6	4.3	4.8	5.3	4.8	3.6
RetentionRatios_A Retention Ratio Ann. %	-10.6%	-	18.48%	1.09%	18.06%	25.90%	-4.47%	-4.82%	78.58%	62.17%	79.97%	79.34%	80.02%
EYield_A Earnings Yield Ann.	-	-	0	0	0	0	0	0	0	0	0	0	0
DEBT_CE_A Total Debt to Total Equity Ann.

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

16.6%

2Y CAGR

-5.4%

3Y CAGR

-6%

5Y CAGR

3.7%

7Y CAGR

6.3%

10Y CAGR

3.1%

ROE Annual % is growing faster than historical averages.

RoA Ann. %

1Y CHG

11.7%

2Y CAGR

-13.3%

3Y CAGR

-9.3%

5Y CAGR

0.8%

7Y CAGR

3.5%

10Y CAGR

-0.2%

RoA Annual % is growing faster than historical averages.

Current Ratio Ann.

1Y CHG

-5%

2Y CAGR

-11%

3Y CAGR

-4.8%

5Y CAGR

-3.7%

7Y CAGR

-2.7%

10Y CAGR

-5.4%

Current Ratio Annual is falling faster than historical averages.

Bayer Cropscience cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Bayer Cropscience Mar-2026 Cash From Operating Activity is Rs 1,078 Cr which is growth of 311.6% YoY.
POSITIVE
Net Cash Flow Bayer Cropscience Mar-2026 Net Cash Flow is Rs 527 Cr which is growth of 294.0% YoY.

Bayer Cropscience Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	21%	9.4%	1,078.5	262	951.6	609.3	215.5	686.7	665.9	432.8	121.4	157.3	196.4
PBT_A PBT Ann.	-4.8%	1.5%	854.9	707.4	941.4	990.1	846.8	794.5	583.1	480	403.8	447.9	462.9
INT_A Interest Ann.	-3.9%	9.5%	19.8	17	19.6	22.3	12.9	12.6	13.8	10.4	11.3	6.9	7.3
TAX_A Tax Ann.	-10.6%	-11.3%	165.7	139.4	200.9	231.9	201.5	301.4	108.6	142.9	103.7	156.9	162
CFI_A Cash from Investing Act. Ann.	-4.5%	61%	72.5	85.6	0.4	83.3	64.2	6.7	-28.9	-414.7	38.3	-8.4	21.8
CFA_A Cash from Financing Act. Ann.	-	-	-623.8	-619.4	-656.3	-613.2	-703.3	-555.8	-148.3	-158.3	-581.1	-73.3	-585.5
NCF_A Net Cash Flow Ann. ⌄	88%	30.8%	527.2	-271.8	295.7	79.4	-423.6	137.6	488.7	-140.2	-421.4	75.6	-367.3
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	4.3%	-3.7%	885.5	1,156.8	860.8	780.9	1,204.5	1,066.9	578.2	718.4	838	762.4	1,129.7
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	18%	3.2%	1,412.7	885	1,156.5	860.3	780.9	1,204.5	1,066.9	578.2	416.6	838	762.4

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

311.6%

2Y CAGR

6.5%

3Y CAGR

21%

5Y CAGR

9.4%

7Y CAGR

13.9%

10Y CAGR

18.6%

Cash from Operating Activity Annual growth is higher than historical averages.

Cash from Investing Act. Ann.

1Y CHG

-15.3%

2Y CAGR

1246.3%

3Y CAGR

-4.5%

5Y CAGR

61%

10Y CAGR

12.8%

Cash from Investing Activity Annual is falling faster than historical averages.

Bayer Cropscience investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

New 52W Low today

High volume today

Bayer Cropscience quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Bayer Cropscience - Forecaster

Forecaster Analyst Estimates for Bayer Cropscience share price target, revenues, EPS, net income and more